Home / HNSA.ST : STO

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does HNSA.ST make money? Does HNSA.ST have pricing power? What's the Earnings Whisper? Will HNSA.ST profit more as the business scales? What is HNSA.ST's management track record? Is HNSA.ST's current price justified?

Hansa Biopharma AB (publ)

SEK 39.34 +$6.64 (+20.31%)

STO · 30 Oct 2026 11:59 UTC

Previous Close

SEK 39.34

Day Range

SEK 39.04SEK 40.00

Year Range

SEK 23.52SEK 48.22

Market Cap

3.92B

AVG Volume

595.63K

Trailing/Forward PE

-5.01/-

PEG ratio

0.05

Dividend Yield

Next Earnings Date

2026-11-11

Primary Exchange

Stockholm Stock Exchange

Revenue (SEK) · Q

HNSA.ST Revenue (SEK) by quarter
Period	Revenue (SEK)
26 Q2	48.1M
26 Q1	34.57M
25 Q4	75.99M
25 Q3	30.8M
25 Q2	49.12M
25 Q1	66.35M
24 Q4	32.34M
24 Q3	48.66M
24 Q2	34.33M
24 Q1	55.98M

Net Income (SEK) · Q

HNSA.ST Net Income (SEK) by quarter
Period	Net Income (SEK)
26 Q2	-260.54M
26 Q1	-196.32M
25 Q4	-165.04M
25 Q3	-148.26M
25 Q2	-178.88M
25 Q1	-37.08M
24 Q4	-276.42M
24 Q3	-103.8M
24 Q2	-207.94M
24 Q1	-218.58M

Operating Income (SEK) · Q

HNSA.ST Operating Income (SEK) by quarter
Period	Operating Income (SEK)
26 Q2	-174.06M
26 Q1	-142.11M
25 Q4	-124.91M
25 Q3	-147.92M
25 Q2	-154.74M
25 Q1	-93.42M
24 Q4	-143.64M
24 Q3	-116.93M
24 Q2	-181.68M
24 Q1	-152.89M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (SEK) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 11 Nov 2026.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Hansa Biopharma AB (publ)

Earnings: HNSA.ST

Video analysis: HNSA.ST

News: HNSA.ST

Similar companies